OLIGOMERIX Completes Series B Financing
5/22/2013 10:22:49 AM
More...
|
OLIGOMERIX Completes $2 Million Series A Financing
4/23/2012 10:25:33 AM
More...
|
A New Mechanism for Tau Protein Pathology in Alzheimer's Disease was Presented by OLIGOMERIX at the Society For Neuroscience Annual Meeting
11/17/2011 11:43:47 AM
More...
|
OLIGOMERIX Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer
10/13/2010 10:40:28 AM
More...
|
OLIGOMERIX Awarded National Institutes of Health (NIH) Grant to Develop Novel Biomarkers for Alzheimer's Disease
2/25/2009 9:10:01 AM
More...
|
OLIGOMERIX Funded by the Alzheimer's Drug Discovery Foundation to Evaluate Compounds Active Against Tau Oligomers, a Novel Target for Therapeutic Development
7/7/2008 8:50:33 AM
More...
|
Victor P. Micati Joins OLIGOMERIX's Board of Directors
8/8/2007 1:15:08 PM
More...
|
OLIGOMERIX Awarded National Institutes of Health (NIH) Grant to Develop Novel Drug Discovery Technology for Alzheimer’s Disease
5/2/2007 1:07:00 PM
More...
|